CeGaT has updated its Diagnostic Panel for Tumor Syndromes. Next to an extension of genes the subpanels for Colon Cancer (CAN01) and Breast and Ovarian Cancers (CAN02) have been subdivided into CAN11, CAN12 and CAN21. Investigations will thus be targeted to smaller subpanels of genes with high and medium risks of cancer. It is possible to later request an extension of an investigation to include other subpanels. The panel now includes thirteen subpanels and a total of 109 genes.
For further information on the Panel, please visit the section for Tumor Syndromes.